Public Release Summary on the evaluation of tiafenacil in the product Terrad'or 700 WG Herbicide

This consultation closed on 1 December 2020.
Consultation period: 
3 November 2020 to 1 December 2020

The APVMA is considering an application for approval of the new active constituent tiafenacil and registration of the product Terrad'or 700 WG Herbicide. 

We invite comment from 3 November 2020 to 1 December 2020 on whether approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety

Download the Public Release Summary on the evaluation of Terrador 700 WG Herbicide.

For more information see page 26, APVMA Gazette No 22. 3 November 2020.

Please note: Submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential (see public submission coversheet).

Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:
Email: enquiries@apvma.gov.au

Post:
Executive Director, Registration Management
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Submissions received

The APVMA sought comments from interested stakeholders on the application for approval of the new active constituent tiafenacil and registration of the product Terrad'or 700 WG Herbicide, in a consultation that closed on 1 December 2020.

A total of 2 submissions were received. Of the submissions, one was from an individual and the other from an industry body.

A copy of published submissions is available on our website.

Consultation feedback

We have completed our review of the submission and finalised registration of the product.

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.